R&D Pipeline Assessment and Market Prospects
Traumatic brain injury (TBI), an acquired damage to the brain that is typically caused by external traumas has been called a silent epidemic. TBI has emerged as the leading cause of central nervous system impairment, ahead of traumatic spinal cord injury.
|
|
Read more...
|
|
|
The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights |
|
Pain continues to present numerous challenges to the biopharmaceutical industry. According to the American Academy of Pain Medicine, over 76 million Americans suffer from pain. Indeed, pain affects more Americans than cancer, diabetes and cardiac disease combined. Current analgesics only provide modest relief, frequently carry black box safety warnings and are susceptible to abuse.
|
|
Read more...
|
|
The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007 |
|
With a market size of US$14.5 billion in 2005 and an anticipated value of US$16.5 billion in 2006, the neurodegenerative market represents a valuable, fast-growing opportunity in the pharma/biotech industry.
|
|
Read more...
|
|
|
|
|
|
|
